These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. TPA for acute ischemic stroke. Fischer J S D J Med; 1997 Feb; 50(2):69-70. PubMed ID: 9062450 [No Abstract] [Full Text] [Related]
3. Thrombolysis in stroke: Between the promise and the peril. Hachinski V JAMA; 1996 Sep; 276(12):995-6. PubMed ID: 8805737 [No Abstract] [Full Text] [Related]
4. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II. Jenkinson D Lancet; 1999 Jan; 353(9146):67-8. PubMed ID: 10023972 [No Abstract] [Full Text] [Related]
5. Stroke busters. New treatments in the fight against 'brain attacks'. Schrof JM US News World Rep; 1999 Mar; 126(10):62-4, 68. PubMed ID: 10346396 [No Abstract] [Full Text] [Related]
6. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II. Ford G; Freemantle N Lancet; 1999 Jan; 353(9146):65; author reply 67-8. PubMed ID: 10023968 [No Abstract] [Full Text] [Related]
7. ECASS-II: intravenous alteplase in acute ischaemic stroke. European Co-operative Acute Stroke Study-II. Raha S Lancet; 1999 Jan; 353(9146):66; author reply 67-8. PubMed ID: 10023970 [No Abstract] [Full Text] [Related]
15. Small but severe residual hypoperfusion relates to symptomatic hemorrhage even after early perfusion improvement in tissue plasminogen activator therapy. Abumiya T; Katoh M; Moriwaki T; Yoshino M; Aoki T; Imamura H; Aida T; Nakayama N; Houkin K Cerebrovasc Dis; 2012; 34(5-6):446-7. PubMed ID: 23207677 [No Abstract] [Full Text] [Related]